ADHD Titration Protocol: Baseline Checks, Dose Adjustments, and Monitoring in the UK
Introduction: Why a Clear Titration Protocol Matters
ADHD titration is the careful, step-by-step process of finding the right medication and dose for each individual. It is one of the most important parts of ADHD treatment because it directly affects how well the medication works, how tolerable the side effects are, and how confident patients feel about their treatment plan.
A clear titration protocol ensures that baseline health checks are completed, dose adjustments are made safely, and ongoing monitoring is consistent. For clinicians, it reduces risk and improves decision-making. For patients, it provides structure, transparency, and reassurance that their treatment is being managed safely.
This guide outlines a practical ADHD titration protocol aligned with UK best practice, covering baseline checks, dose adjustment strategies, and ongoing monitoring requirements.
Step 1: Baseline Checks Before Starting Medication
Before any ADHD medication is started, a thorough baseline assessment is essential. This ensures the person is suitable for treatment and highlights any risk factors that need attention.
Medical and Psychiatric History
The prescriber should review:
Full ADHD assessment and diagnosis
Medical history, including cardiovascular, neurological, and endocrine conditions
Psychiatric history, including anxiety, depression, bipolar disorder, psychosis, and substance use
Current medications, supplements, and recreational substances
Family history of sudden cardiac death or serious heart conditions
This helps identify contraindications and informs medication choice.
Physical Observations
Baseline physical measurements are a core part of the protocol. These typically include:
Blood pressure – to identify hypertension or hypotension
Pulse/heart rate – to detect tachycardia or arrhythmias
Weight – to monitor appetite effects and nutritional status
Height – especially important in children and young people for growth monitoring
BMI – useful context for weight changes during treatment
In some cases, an ECG or blood tests may be requested if there are specific cardiac or medical concerns.
Functional Baseline
It is also helpful to record baseline functioning across key areas:
Work, school, or academic performance
Organisation, time management, and daily routines
Relationships and social functioning
Emotional regulation and mood
Standardised rating scales (e.g., ASRS for adults, parent/teacher scales for children) can provide a useful baseline for comparison during titration.
Step 2: Starting Dose and Initial Titration Phase
Once baseline checks are complete, medication can be started at a low, conservative dose.
Choosing the First Medication
In the UK:
Adults: lisdexamfetamine or methylphenidate are commonly used first-line
Children and adolescents: methylphenidate is typically first-line, with lisdexamfetamine considered if ineffective or not tolerated
Non-stimulants such as atomoxetine may be used if stimulants are not suitable.
Starting Doses
Typical starting doses include:
Methylphenidate: often 5 mg twice daily or a low-dose modified-release formulation
Lisdexamfetamine: typically 30 mg once daily in adults and children aged 6+
Atomoxetine: usually started at a lower dose and increased gradually over several weeks
The exact starting point depends on age, formulation, clinical history, and risk factors.
Initial Titration Phase (Weeks 1–4)
During the first 2–4 weeks:
Weekly contact (in-person, video, or telephone) is recommended to assess response and side effects
Blood pressure and pulse should be checked at each dose adjustment
Weight should be monitored, especially if appetite suppression is significant
Symptom ratings and functional feedback are collected to guide dose changes
The goal is to make small, incremental adjustments while closely monitoring tolerability.
Step 3: Dose Adjustment Strategies
Dose adjustments are the core of titration. The aim is to find the lowest effective dose that provides meaningful symptom control with acceptable side effects.
Principles of Dose Adjustment
Start low, go slow: increase gradually to minimise side effects
Change one variable at a time: adjust dose before changing formulation or adding medications
Use objective and subjective data: combine symptom ratings, side effect reports, and functional feedback
Pause or reduce if needed: if side effects are significant, hold the dose or reduce before increasing again
Typical Adjustment Patterns
Methylphenidate: often increased by 5–10 mg per dose weekly, depending on response
Lisdexamfetamine: typically increased by 10–20 mg weekly, up to a maximum of 70 mg/day
Atomoxetine: increased more gradually over several weeks, as effects build slowly
Dose adjustments should always be individualised based on clinical response and tolerability.
Managing Common Issues
Poor response: consider increasing the dose, switching formulation, or trying a different medication class
Side effects: reduce dose, adjust timing, or switch to a different formulation (e.g., extended-release)
Emotional changes: irritability, low mood, or anxiety should be monitored closely and may require dose reduction or medication change
Appetite and sleep issues: adjust timing, consider nutritional support, or review dose level
Keeping a daily symptom and side-effect diary can help guide these decisions.
Step 4: Stabilisation and Ongoing Monitoring
Once an effective and tolerable dose is reached, the focus shifts to stabilisation and long-term monitoring.
Criteria for Stabilisation
Titration is considered complete when:
ADHD symptoms are well controlled across settings
Side effects are minimal or manageable
The patient and clinician agree the dose is stable
At this point, a titration summary is often issued, and a shared care agreement may be requested from the GP for ongoing prescribing.
Ongoing Monitoring Schedule
After stabilisation, monitoring typically follows this pattern:
Adults: at least annual review, with more frequent check-ins if mood or side effect concerns arise
Children and young people: reviews every 3–6 months, including growth monitoring
All patients: blood pressure, pulse, and weight checked at each review
Additional monitoring may include:
Sleep quality and timing
Appetite and nutritional adequacy
Mood, anxiety, and emotional regulation
Functional outcomes at work, school, and home
Substance use screening (especially in adolescents and adults)
Red Flags Requiring Earlier Review
Patients should be advised to contact their care team promptly if they experience:
New or worsening chest pain, palpitations, or fainting
Severe mood changes, suicidal thoughts, or psychotic symptoms
Significant weight loss or inability to eat adequately
Severe insomnia or daytime impairment
Early intervention can prevent complications and improve long-term outcomes.
Documentation and Communication
Good documentation is a key part of any titration protocol.
What Should Be Documented
Baseline history and physical observations
Medication choice and rationale
Dose adjustments and clinical reasoning
Side effects and how they were managed
Symptom and functional outcomes at each stage
Plan for ongoing monitoring and shared care
Clear records support continuity of care, especially when multiple clinicians or services are involved.
Communication with GPs and Other Services
Once stable, the specialist typically writes to the GP requesting ongoing prescribing and routine monitoring. This includes:
Diagnosis and treatment summary
Current medication and dose
Monitoring requirements (e.g., BP, pulse, weight every 6–12 months)
Red flags and escalation pathways
Effective communication reduces the risk of gaps in care and supports successful shared care agreements.
FAQs: ADHD Titration Protocol
What baseline checks are needed before starting ADHD medication?
Baseline checks include medical and psychiatric history, blood pressure, pulse, weight, height (in children), and functional assessment. An ECG or blood tests may be needed in specific cases.
How often should dose adjustments be reviewed during titration?
During the first 2–4 weeks, weekly contact is recommended. After that, reviews occur at least monthly until symptoms are fully stabilised.
What physical measurements are monitored during titration?
Blood pressure, pulse, and weight are monitored at each dose adjustment. Height is also tracked in children and young people for growth monitoring.
How are dose decisions made during titration?
Dose decisions are based on symptom improvement, side effects, functional outcomes, and patient preference, using both self-report and collateral information where possible.
What happens if side effects occur during titration?
Side effects may be managed by reducing the dose, adjusting timing, switching formulation, or changing medication. Severe or persistent side effects should be reported promptly.
How often are reviews needed once stable?
Adults typically have at least annual reviews, while children and young people are reviewed every 3–6 months. More frequent check-ins are needed if mood or side effect concerns arise.
Can titration be done remotely?
Yes. Many services offer remote titration with video or telephone reviews, as long as safety checks and monitoring are in place.
Book Your ADHD Assessment Today
If you are struggling with focus, organisation, impulsivity, or emotional regulation, you do not have to navigate it alone. A thorough ADHD assessment is the first step toward understanding your symptoms and exploring treatment options, including safe, supported titration.
At Focus Gently, we are committed to clear, compassionate, and evidence-based ADHD care. From assessment through titration and ongoing support, our goal is to help you move forward with confidence.
Ready to take the next step?
Book your ADHD assessment today at https://www.focusgently.com/ and start your journey toward clearer focus, better organisation, and greater control over your day.
